Extending the Medica experiment by three years: six million dollars extra bets on tech pioneers outside major hubs
Early-stage financing experiments demonstrate that access to capital remains a structural challenge outside closed circles.The early-stage investment program Medica, dedicated to supporting startups in Africa, announced an additional financing commitment of $6 million from the Flourish Ventures fund to extend its pilot phase by three years. The step aims to invest in 25 to 30 new companies at the earliest founding stage, focusing on founders whom traditional venture capital networks cannot reach or support with sufficient resources.
The program launched in 2022 under the leadership of Emmanuel Adigbwi, in a founding partnership with Evayomi Car, the investment partner at Flourish Ventures, aiming to provide flexible financing and direct operational support for building companies. Since its launch, the program has invested in 18 startups across ten African countries and twelve technology and industrial sectors, including artificial intelligence, climate technology, semiconductors, biotechnology, human resources, and mobility solutions. Portfolio data show that the firms receiving this support later raised additional capital averaging twice the amount invested by the program, reflecting the success of the support model in attracting confidence from later-stage investors.
Applicant numbers reveal the depth of untapped capabilities outside the usual investment capitals.The program received applications from founders representing 78 countries and 28 sectors, with 40 % of the applications originating from outside the continent’s four largest venture-capital markets. The current portfolio is predominantly African-owned across all firms, includes more than 50 % of companies with at least one co-founder, and 39 % are led by female CEOs. Emmanuel Adigbwi notes that the past three years have provided practical lessons and early growth signals, but building sustainable companies and assessing actual returns and exit pathways requires a longer time horizon, which the new extension offers to gather decisive evidence that all investors can use.
The program sets specific conditions for companies wishing to join its new cycle: the headquarters must be located within Africa, they must have an applicable prototype product already serving paying customers, the founders must work full-time, and the company must not have received prior institutional funding or have only extremely limited financing. Evayomi Car affirms that the program’s founding conviction remains unchanged: exceptional talent can build globally competitive companies if they have capital paired with rigorous institutional guidance.
This approach reshapes the baseline calculations for early-stage investment for entrepreneurs and investment funds in Egypt, North Africa, and the Gulf.For early-stage tech companies in North Africa, and Egypt in particular, the multi-sector financing model opens an alternative to inflated valuations, making acceptance criteria a critical operational lesson: demonstrate viability with paying customers before pursuing venture-capital rounds. Conversely, Gulf family offices and investment desks seeking diversification beyond delivery and consumer-commerce applications see semiconductor, artificial-intelligence, and climate-technology sectors in emerging markets as evidence that deep-impact projects can be supported with disciplined early capital that yields multiplied returns.
The experiment presented by Medica constitutes a live test of the ability of founder-focused financing, not merely cash infusion, to dismantle excessive centralization in the technology sector. If the model succeeds in generating genuine exit pathways over the next three years, it will not only reorient investors toward under-tapped talent on the continent, but also provide the entire regional entrepreneurship ecosystem with a practical benchmark for measuring early-stage capital efficiency against complex structural challenges.